From 2024 to 2028, the forecasted government expenditure on R&D in medical and health sciences in Germany shows a consistent upward trend. The expenditure is expected to increase from 2.78 billion USD PPP in 2024 to 3.43 billion USD PPP in 2028. Compared to the last two years, the year-on-year percentage change for 2025 and 2026 are 6.12% and 5.42%, respectively. The compound annual growth rate (CAGR) over the five-year period is approximately 5.22%.
Future trends to watch for include potential policy shifts in government spending priorities, continued advancements in medical technology, and the impact of global health challenges, which could further influence R&D investments and related growth projections.
